Eskandrani, R.; Al-Rasheed, L.S.; Ansari, S.A.; Bakheit, A.H.; Almehizia, A.A.; Almutairi, M.; Alkahtani, H.M.
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies. Molecules 2023, 28, 4271.
https://doi.org/10.3390/molecules28114271
AMA Style
Eskandrani R, Al-Rasheed LS, Ansari SA, Bakheit AH, Almehizia AA, Almutairi M, Alkahtani HM.
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies. Molecules. 2023; 28(11):4271.
https://doi.org/10.3390/molecules28114271
Chicago/Turabian Style
Eskandrani, Razan, Lamees S. Al-Rasheed, Siddique Akber Ansari, Ahmed H. Bakheit, Abdulrahman A. Almehizia, Maha Almutairi, and Hamad M. Alkahtani.
2023. "Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies" Molecules 28, no. 11: 4271.
https://doi.org/10.3390/molecules28114271
APA Style
Eskandrani, R., Al-Rasheed, L. S., Ansari, S. A., Bakheit, A. H., Almehizia, A. A., Almutairi, M., & Alkahtani, H. M.
(2023). Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies. Molecules, 28(11), 4271.
https://doi.org/10.3390/molecules28114271
